Cardiac Biomarkers Market Analysis, Trends & Statistics - 2032

Cardiac Biomarkers Market Size - By Product (Troponins, CK-MB, Myoglobin, Natriuretic Peptides, CRP, Ischemia Modified Albumin), Application, End-use – Global Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; workings

1.3&nbsp;&nbsp;&nbsp; Forecast calculations

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

1.4.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.4.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Global cardiac biomarkers market 360&deg; synopsis, 2018 &ndash; 2032

2.2&nbsp;&nbsp;&nbsp; Regional trends

2.3&nbsp;&nbsp;&nbsp; Product trends

2.4&nbsp;&nbsp;&nbsp; Application trends

2.5&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Cardiac Biomarkers Industry Insights

3.1&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.2&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.3&nbsp;&nbsp;&nbsp; Technology landscape

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Industry impact forces

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.1.1&nbsp;&nbsp;&nbsp;Increase in prevalence of cardiovascular diseases

3.5.1.2&nbsp;&nbsp;&nbsp;Rise in the elderly population is leading to a higher prevalence of heart-related conditions

3.5.1.3&nbsp;&nbsp;&nbsp;Rising clinical research studies aimed at discovering new cardiac biomarkers

3.5.1.4&nbsp;&nbsp;&nbsp;Increase in point-of-care testing

3.5.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.5.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory frameworks

3.5.2.2&nbsp;&nbsp;&nbsp;Presence and advancement in cardiac imaging technologies

3.6&nbsp;&nbsp;&nbsp; Growth potential analysis

3.6.1&nbsp;&nbsp;&nbsp; By product

3.6.2&nbsp;&nbsp;&nbsp; By application

3.6.3&nbsp;&nbsp;&nbsp; By end-use

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Abbott Diagnostics

4.1.2&nbsp;&nbsp;&nbsp; Roche Diagnostics

4.1.3&nbsp;&nbsp;&nbsp; Siemens Healthineers

4.2&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix, 2022

4.4&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Cardiac Biomarkers Market Size and Forecast, By Product, 2018-2032 (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by product

5.2&nbsp;&nbsp;&nbsp; Troponins

5.3&nbsp;&nbsp;&nbsp; Creatine kinase-MB (CK-MB)

5.4&nbsp;&nbsp;&nbsp; Myoglobin

5.5&nbsp;&nbsp;&nbsp; Natriuretic peptides

5.6&nbsp;&nbsp;&nbsp; C-reactive protein (CRP)

5.7&nbsp;&nbsp;&nbsp; Ischemia modified albumin

5.8&nbsp;&nbsp;&nbsp; Other products

Chapter 6&nbsp;&nbsp;&nbsp;Cardiac Biomarkers Market Size and Forecast, By Application, 2018-2032 (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by application

6.2&nbsp;&nbsp;&nbsp; Congestive heart failure

6.3&nbsp;&nbsp;&nbsp; Myocardial infarction

6.4&nbsp;&nbsp;&nbsp; Acute coronary syndrome

6.5&nbsp;&nbsp;&nbsp; Atherosclerosis

6.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 7&nbsp;&nbsp;&nbsp;Cardiac Biomarkers Market Size and Forecast, By End-use, 2018-2032 (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

7.2&nbsp;&nbsp;&nbsp; Hospital laboratory

7.3&nbsp;&nbsp;&nbsp; Point of care testing facilities

7.4&nbsp;&nbsp;&nbsp; Diagnostic facilities

7.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Cardiac Biomarkers Market Size and Forecast, By Region, 2018-2032 (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by region

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.2&nbsp;&nbsp;&nbsp; South Africa

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Diagnostics

9.2&nbsp;&nbsp;&nbsp; Roche Diagnostics

9.3&nbsp;&nbsp;&nbsp; Siemens Healthineers

9.4&nbsp;&nbsp;&nbsp; Beckman Coulter

9.5&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

9.6&nbsp;&nbsp;&nbsp; Ortho Clinical Diagnostics

9.7&nbsp;&nbsp;&nbsp; Randox Laboratories

9.8&nbsp;&nbsp;&nbsp; Quidel Corporation

9.9&nbsp;&nbsp;&nbsp; Radiometer

9.10&nbsp;&nbsp;&nbsp; Tosoh Corporation

9.11&nbsp;&nbsp;&nbsp; Meso Scale Diagnostics (MSD)

9.12&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

9.13&nbsp;&nbsp;&nbsp; Luminex Corporation

9.14&nbsp;&nbsp;&nbsp; Trinity Biotech

9.15&nbsp;&nbsp;&nbsp; Biomerieux

&nbsp;&nbsp;&nbsp;

Cardiac Biomarkers Market

Get a free sample of this report